These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 21410323

  • 1. Insulin-like growth factor-2 (IGF-2) activates estrogen receptor-α and -β via the IGF-1 and the insulin receptors in breast cancer cells.
    Richardson AE, Hamilton N, Davis W, Brito C, De León D.
    Growth Factors; 2011 Apr; 29(2-3):82-93. PubMed ID: 21410323
    [Abstract] [Full Text] [Related]

  • 2. Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells.
    Karl M, Potier M, Schulman IH, Rivera A, Werner H, Fornoni A, Elliot SJ.
    Endocrinology; 2005 Feb; 146(2):889-900. PubMed ID: 15550505
    [Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells.
    Sarfstein R, Pasmanik-Chor M, Yeheskel A, Edry L, Shomron N, Warman N, Wertheimer E, Maor S, Shochat L, Werner H.
    J Biol Chem; 2012 Jan 20; 287(4):2766-76. PubMed ID: 22128190
    [Abstract] [Full Text] [Related]

  • 4. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk.
    Klotz DM, Hewitt SC, Ciana P, Raviscioni M, Lindzey JK, Foley J, Maggi A, DiAugustine RP, Korach KS.
    J Biol Chem; 2002 Mar 08; 277(10):8531-7. PubMed ID: 11751931
    [Abstract] [Full Text] [Related]

  • 5. Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cells.
    Morelli C, Lanzino M, Garofalo C, Maris P, Brunelli E, Casaburi I, Catalano S, Bruno R, Sisci D, Andò S.
    Mol Cell Biol; 2010 Feb 08; 30(3):857-70. PubMed ID: 19933843
    [Abstract] [Full Text] [Related]

  • 6. A Role for ER-Beta in the Effects of Low-Density Lipoprotein Cholesterol and 27-Hydroxycholesterol on Breast Cancer Progression: Involvement of the IGF Signalling Pathway?
    Mashat RM, Zielinska HA, Holly JMP, Perks CM.
    Cells; 2021 Dec 29; 11(1):. PubMed ID: 35011656
    [Abstract] [Full Text] [Related]

  • 7. The expression of estrogen receptor isoforms alpha, beta and insulin-like growth factor-I in uterine leiomyoma.
    Zhao Y, Zhang W, Wang S.
    Gynecol Endocrinol; 2008 Oct 29; 24(10):549-54. PubMed ID: 19012097
    [Abstract] [Full Text] [Related]

  • 8. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
    Bradley LM, Gierthy JF, Pentecost BT.
    J Steroid Biochem Mol Biol; 2008 Mar 29; 109(1-2):185-96. PubMed ID: 18337089
    [Abstract] [Full Text] [Related]

  • 9. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
    Iida M, Tsuboi K, Niwa T, Ishida T, Hayashi SI.
    Breast Cancer; 2019 May 29; 26(3):272-281. PubMed ID: 30328006
    [Abstract] [Full Text] [Related]

  • 10. Estrogen receptor alpha (ERalpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alphaT3-1 cell line.
    Eertmans F, Dhooge W, De Wever O, Bracke M, Comhaire F, Kaufman JM.
    J Cell Physiol; 2007 Sep 29; 212(3):583-90. PubMed ID: 17458895
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
    Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D.
    Mol Endocrinol; 1999 May 29; 13(5):787-96. PubMed ID: 10319328
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM, Colston K, Jiang WG, Sharma AK, Mokbel K.
    Breast Cancer Res Treat; 2006 Oct 29; 99(3):275-88. PubMed ID: 16752221
    [Abstract] [Full Text] [Related]

  • 19. Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer.
    Lanzino M, Morelli C, Garofalo C, Panno ML, Mauro L, Andò S, Sisci D.
    Curr Cancer Drug Targets; 2008 Nov 29; 8(7):597-610. PubMed ID: 18991569
    [Abstract] [Full Text] [Related]

  • 20. Insulin Receptor Substrate Suppression by the Tyrphostin NT157 Inhibits Responses to Insulin-Like Growth Factor-I and Insulin in Breast Cancer Cells.
    Yang Y, Chan JY, Temiz NA, Yee D.
    Horm Cancer; 2018 Dec 29; 9(6):371-382. PubMed ID: 30229539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.